BR112015015938A2 - uso de cloridrato de fenilefrina e paracetamol, medicamento, método de tratamento de congestão das mucosas do trato respiratório superior em um humano adulto - Google Patents
uso de cloridrato de fenilefrina e paracetamol, medicamento, método de tratamento de congestão das mucosas do trato respiratório superior em um humano adultoInfo
- Publication number
- BR112015015938A2 BR112015015938A2 BR112015015938A BR112015015938A BR112015015938A2 BR 112015015938 A2 BR112015015938 A2 BR 112015015938A2 BR 112015015938 A BR112015015938 A BR 112015015938A BR 112015015938 A BR112015015938 A BR 112015015938A BR 112015015938 A2 BR112015015938 A2 BR 112015015938A2
- Authority
- BR
- Brazil
- Prior art keywords
- phenylephrine
- drug
- respiratory tract
- pharmaceutically acceptable
- upper respiratory
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
resumo uso de cloridrato de fenilefrina e paracetamol, medicamento, método de tratamento de congestão das mucosas do trato respiratório superior em um humano adulto uso de cloridrato de fenilefrina (ou uma forma alternativa farmaceuticamente aceitável de fenilefrina) e paracetamol na produção de um medicamento combinado para tratamento de congestão das mucosas do trato respiratório superior, compreendendo a combinação de tais substâncias com excipientes, caracterizado pelo fato de o medicamento apresentar o cloridrato de fenilefrina (ou a forma alternativa farmaceuticamente aceitável de fenilefrina) e paracetamol em proporções adequadas, e o medicamento se destina, para a administração a um adulto de: a) 4 mg 7,5 mg de cloridrato de fenilefrina (ou uma quantidade equivalente de uma forma alternativa farmaceuticamente aceitável), em combinação com 950 mg 1.000 mg de paracetamol; ou b) 5 mg 7,5 mg de cloridrato de fenilefrina (ou uma quantidade equivalente de uma forma alternativa farmaceuticamente aceitável de fenilefrina), em combinação com 600 mg 700 mg de paracetamol; ou c) 6 mg 8 mg de cloridrato de fenilefrina (ou uma quantidade equivalente de uma forma alternativa farmaceuticamente aceitável de fenilefrina), em combinação com 500 mg 550 mg de paracetamol.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ60665913 | 2013-02-04 | ||
| NZ61013213 | 2013-05-02 | ||
| NZ61391813 | 2013-08-02 | ||
| NZ61802713 | 2013-11-20 | ||
| PCT/NZ2014/000001 WO2014120021A1 (en) | 2013-02-04 | 2014-01-07 | A combination medicament comprising phenylephrine and paracetamol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112015015938A2 true BR112015015938A2 (pt) | 2017-07-11 |
Family
ID=51262632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015015938A BR112015015938A2 (pt) | 2013-02-04 | 2014-01-07 | uso de cloridrato de fenilefrina e paracetamol, medicamento, método de tratamento de congestão das mucosas do trato respiratório superior em um humano adulto |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP2830605B8 (pt) |
| CN (2) | CN107811999A (pt) |
| AP (1) | AP2015008704A0 (pt) |
| BR (1) | BR112015015938A2 (pt) |
| CA (1) | CA2893836C (pt) |
| EC (1) | ECSP15033649A (pt) |
| LU (1) | LU92526B1 (pt) |
| MX (2) | MX2015009681A (pt) |
| PE (1) | PE20151282A1 (pt) |
| PH (1) | PH12015501294A1 (pt) |
| PL (1) | PL2830605T3 (pt) |
| RS (1) | RS64807B1 (pt) |
| SG (1) | SG11201504389QA (pt) |
| TW (1) | TW201434464A (pt) |
| WO (1) | WO2014120021A1 (pt) |
| ZA (1) | ZA201504080B (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070249727A1 (en) | 2006-04-21 | 2007-10-25 | The Proctor & Gamble Company | Compositions and kits useful for treatment of respiratory illness |
| US10022339B2 (en) | 2006-04-21 | 2018-07-17 | The Procter & Gamble Company | Compositions and methods useful for treatment of respiratory illness |
| HUE053181T2 (hu) | 2015-05-21 | 2021-06-28 | Abdi Ibrahim Ilac Sanayi Ve Ticaret A S | Gyógyszerészeti készítmény megnövelt oldékonysággal és stabilitással |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4260600A (en) * | 1979-10-22 | 1981-04-07 | Ronald Valle | Method of treating depression |
| US20040162273A1 (en) * | 2003-01-23 | 2004-08-19 | The Procter & Gamble Company | Powder pharmaceutical compositions |
| GB2443793B (en) | 2006-04-05 | 2010-12-01 | Reckitt Benckiser Healthcare | Product, method of manufacture and use |
| US20070254027A1 (en) * | 2006-04-28 | 2007-11-01 | The Procter & Gamble Company | Compositions and methods useful for treatment of respiratory illness |
| AU2008280801B2 (en) | 2007-07-23 | 2014-03-06 | Kingsway Pharmaceuticals Inc. | Therapeutic formulations for the treatment of cold and flu-like symptoms |
| MX2010010275A (es) * | 2008-03-17 | 2010-09-30 | Procter & Gamble | Sistema de dosificacion personalizable por el usuario. |
| US8518439B2 (en) * | 2008-12-03 | 2013-08-27 | Novartis Ag | Liquid therapeutic composition |
| US20110104272A1 (en) * | 2009-11-05 | 2011-05-05 | Depomed, Inc. | Gastric retentive extended-release dosage forms comprising combinations of acetaminophen and phenylephrine |
| WO2012090218A1 (en) * | 2010-12-30 | 2012-07-05 | Zota Health Care Ltd | Synergistic effects of the combination of the specific compounds with paracetamol and their effects on various diseases |
-
2014
- 2014-01-07 CN CN201711276478.7A patent/CN107811999A/zh active Pending
- 2014-01-07 SG SG11201504389QA patent/SG11201504389QA/en unknown
- 2014-01-07 BR BR112015015938A patent/BR112015015938A2/pt not_active Application Discontinuation
- 2014-01-07 PL PL14746905.0T patent/PL2830605T3/pl unknown
- 2014-01-07 PE PE2015001231A patent/PE20151282A1/es unknown
- 2014-01-07 AP AP2015008704A patent/AP2015008704A0/xx unknown
- 2014-01-07 RS RS20230953A patent/RS64807B1/sr unknown
- 2014-01-07 WO PCT/NZ2014/000001 patent/WO2014120021A1/en active Application Filing
- 2014-01-07 EP EP14746905.0A patent/EP2830605B8/en active Active
- 2014-01-07 CA CA2893836A patent/CA2893836C/en not_active Expired - Fee Related
- 2014-01-07 CN CN201480003659.0A patent/CN104936585B/zh active Active
- 2014-01-07 MX MX2015009681A patent/MX2015009681A/es unknown
- 2014-01-07 LU LU92526A patent/LU92526B1/xx active
- 2014-01-29 TW TW103103365A patent/TW201434464A/zh not_active IP Right Cessation
-
2015
- 2015-06-05 PH PH12015501294A patent/PH12015501294A1/en unknown
- 2015-06-05 ZA ZA2015/04080A patent/ZA201504080B/en unknown
- 2015-07-27 MX MX2021001845A patent/MX2021001845A/es unknown
- 2015-08-03 EC ECIEPI201533649A patent/ECSP15033649A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2021001845A (es) | 2021-05-13 |
| AP2015008704A0 (en) | 2015-09-30 |
| EP2830605A4 (en) | 2015-02-04 |
| EP2830605B8 (en) | 2023-11-08 |
| CN104936585A (zh) | 2015-09-23 |
| TW201434464A (zh) | 2014-09-16 |
| PH12015501294A1 (en) | 2015-08-24 |
| SG11201504389QA (en) | 2015-08-28 |
| MX2015009681A (es) | 2016-07-11 |
| EP2830605A1 (en) | 2015-02-04 |
| PE20151282A1 (es) | 2015-10-04 |
| CN107811999A (zh) | 2018-03-20 |
| CA2893836A1 (en) | 2014-08-07 |
| TWI514998B (pt) | 2016-01-01 |
| LU92526B1 (fr) | 2014-12-22 |
| ZA201504080B (en) | 2016-04-28 |
| ECSP15033649A (es) | 2015-11-30 |
| EP2830605B1 (en) | 2023-09-27 |
| CA2893836C (en) | 2017-05-02 |
| CN104936585B (zh) | 2017-11-14 |
| PL2830605T3 (pl) | 2024-02-19 |
| WO2014120021A1 (en) | 2014-08-07 |
| RS64807B1 (sr) | 2023-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2016000530A1 (es) | Tratamiento de la osteoartritis y del dolor (divisional de sol. n°2298-13). | |
| BR112015025464A2 (pt) | coagonistas do receptor de glp-1/glucagon estáveis, prolongados para uso médico | |
| PH12015502691A1 (en) | Use of high dose pridopidine for treating huntington's disease | |
| BR112015018168A2 (pt) | inibidores de rock suaves | |
| MX2022003072A (es) | Uso de pridopidina para el tratamiento de la disminucion funcional. | |
| BR112016001678A2 (pt) | Composição, método de fabricação de um comprimido, comprimido, forma de dosagem unitária, artigo de fabricação, e, uso de uma composição, de um comprimido ou de uma forma de dosagem unitária | |
| CL2015002733A1 (es) | Composición farmacéutica de clorhidrato de s-cetamina. | |
| EA201591363A1 (ru) | Аналоги тиадиазола и способы лечения состояний, связанных с дефицитом smn | |
| MX2021002321A (es) | Nuevos metodos. | |
| BR112015010039A2 (pt) | tratamento de câncer com pomalidomida em um individuo com disfunção renal | |
| WO2014164285A3 (en) | Use of levocetirizine and montelukast in the treatment of vasculitis | |
| EA201690974A1 (ru) | Гидроморфон и налоксон для лечения боли и индуцированного опиоидами синдрома дисфункции кишечника | |
| UA118474C2 (uk) | (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині | |
| TR201819662T4 (tr) | Çocukluk çağı hipertansiyon tedavisinde kullanılan enalapril içeren ağızda dağılan film bileşimi. | |
| BR112015015938A2 (pt) | uso de cloridrato de fenilefrina e paracetamol, medicamento, método de tratamento de congestão das mucosas do trato respiratório superior em um humano adulto | |
| EA201591415A1 (ru) | Фармацевтические композиции, включающие многокомпонентные кристаллические частицы, подходящие для применения в ингаляционной терапии | |
| EA202090164A1 (ru) | Изотретиноиновые перорально-слизистые композиции и способы их применения | |
| BR112019001134A2 (pt) | uso de lactama e composição farmacêutica | |
| CY1120749T1 (el) | Φαρμακευτικες δοσολογικες μορφες | |
| IN2013MU03428A (pt) | ||
| CO2018010142A2 (es) | Proceso de preparación de fórmulas solidas de mesalazina | |
| ES2475942B1 (es) | Composición farmacéutica de citrato de sildenafilo en forma de solución acuosa | |
| PH12016502107A1 (en) | Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders | |
| AR095149A1 (es) | Medicamento que comprende fenilefrina y paracetamol | |
| AR091633A1 (es) | Solucion inyectable de acetaminofen para su administracion por via espinal |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] |